[Current status and prospects of integrated traditional Chinese and Western medicine for treatment of portal hypertension].

Zhonghua Gan Zang Bing Za Zhi

Center of Therapeutic Research for Hepatocellular Carcinoma, The 302nd Hospital, Beijing 100039, China.

Published: April 2018

Portal hypertension refers to a series of clinical manifestations caused by elevated pressure of the portal vein system, which can cause portal hypertension by causing portal venous obstruction and / or increased blood flow. A typical clinical manifestation in patients with decompensated cirrhosis is portal hypertension. A severe complication of portal hypertension is esophagogastric varices bleeding, refractory ascites, and hepatic encephalopathy. The effective reduction of portal pressure can reduce the incidence of complications, improve the prognosis and reduce the mortality. At present, the commonly used clinical methods for reducing portal hypertension include drug therapy, minimally invasive interventions, surgical treatment, and liver transplantation. This article reviews the current status of integrated traditional Chinese and Western medicine for portal hypertension.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1007-3418.2018.04.003DOI Listing

Publication Analysis

Top Keywords

portal hypertension
24
portal
10
integrated traditional
8
traditional chinese
8
chinese western
8
western medicine
8
hypertension
6
[current status
4
status prospects
4
prospects integrated
4

Similar Publications

Acute gastric variceal bleeding is a rare but serious complication of portal hypertension. Initial therapy for bleeding gastric varices focuses on acute hemostasis. In this regard, endoscopic cyanoacrylate injection (ECI) is the first-line approach.

View Article and Find Full Text PDF

Common variable immunodeficiency (CVID) is a type of primary immunodeficiency that presents as a heterogenous disorder characterized by hypogammaglobinemia, poor response to vaccines, recurrent sinopulmonary infections, and can have noninfectious systemic manifestations. We performed a single-center, retrospective, observational study of five patients with noninfectious complications of CVID. All patients had CVID as defined by the European Society of Immunodeficiencies criteria and had received intravenous immunoglobulin therapy.

View Article and Find Full Text PDF

Outpatient management after hospitalisation for acute decompensation of cirrhosis: A practical guide.

World J Hepatol

December 2024

Fourth Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki 54642, Greece.

Acute decompensation in cirrhotic patients signifies the onset of clinically evident events due to portal hypertension. The transition from compensated to decompensated cirrhosis involves hemodynamic changes leading to multiorgan dysfunction, managed predominantly in outpatient settings with regular monitoring. The mortality risk is elevated in decompensated patients.

View Article and Find Full Text PDF

[Statin for the prevention and treatment of hepatocellular carcinoma: use or wait?].

Zhonghua Gan Zang Bing Za Zhi

January 2025

The First Clinical Medical College of Lanzhou University, Lanzhou730000, China Department of Hepatology & Infectious Diseases, the First Hospital of Lanzhou University, Lanzhou, 730000, China Institute of Portal Hypertension, the First Hospital of Lanzhou University, Lanzhou730000, China.

Hepatocellular carcinoma (HCC) is a kind of malignant tumor with an extremely high morbidity and mortality incidence rate. Although some new progress has been made in recent treatment, the overall prognosis is still poor. Therefore, the prevention and treatment of HCC have important clinical significance.

View Article and Find Full Text PDF

Objectives: Frailty is a well-known complication of chronic liver disease and has been recognized as a poor prognostic factor in cirrhotic patients being associated with increased morbidity and mortality. There is limited available pediatric literature in this regard. The current study aimed to estimate the prevalence of frailty and analyze the predictive factors and their association with long-term outcomes in children with liver disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!